Brian Safina

Brian Safina

Company: Bolt Biotherapeutics

Job title: Vice President - Chemistry


Brian Safina, Ph.D., serves as vice president for Bolt Biotherapeutics, where he leads chemistry and bioconjugation toward developing novel immuno-oncology therapeutics.  He joined Bolt in 2018 with over a decade of medicinal chemistry experience at Genentech.  Dr. Safina has made significant contributions to the discovery of multiple clinical candidates in the areas of oncology, immunology and neuroscience.  Dr. Safina holds a Ph.D. in organic chemistry from the University of California, San Diego, where he worked in the laboratories of K.C. Nicolaou.   


Live Discussion & Question Time 5:00 pm

Read more

day: Day Two

Tumor-Targeted Immune-Stimulating Antibody Conjugates (ISAC): A New Class of Immuno-oncology Therapeutics 4:20 pm

• Introducing Bolt’s ISAC technology platform as the next evolution in immune-oncology and antibody drug conjugates • Showcasing key features of ISAC technology and mechanism of action • Demonstrating the promise of the ISAC platform and Bolt’s approach to develop this new classRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.